Rebreathe Medical Devices India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.50 M
as on 16-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 368.92%
(FY 2023)
- Profit 25.56%
(FY 2023)
- Ebitda 24.92%
(FY 2023)
- Net Worth 89.41%
(FY 2023)
- Total Assets 251.37%
(FY 2023)
About Rebreathe Medical Devices India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Rai, Anupam Gupta, and Arun Handa serve as directors at the Company.
- CIN/LLPIN
U33119DL2021PTC383180
- Company No.
383180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rebreathe Medical Devices India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Gupta  | Director | 05-Jul-2021 | Current |
| Rajesh Rai | Director | 27-Feb-2023 | Current |
| Arun Handa | Whole-Time Director | 05-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Rebreathe Medical Devices India.
Rebreathe Medical Devices India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 368.92% increase. The company also saw a substantial improvement in profitability, with a 25.56% increase in profit. The company's net worth Soared by an impressive increase of 89.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rebreathe Medical Devices India?
In 2023, Rebreathe Medical Devices India had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Servotech Power Systems LimitedActive 20 years 2 monthsRajesh Rai and Anupam Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rebreathe Medical Devices India?
Rebreathe Medical Devices India has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rebreathe Medical Devices India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebreathe Medical Devices India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
